Digestive Diseases and Sciences

, Volume 63, Issue 4, pp 890–899 | Cite as

Long Noncoding RNA GAPLINC Promotes Cells Migration and Invasion in Colorectal Cancer Cell by Regulating miR-34a/c-MET Signal Pathway

  • Yuqi Luo
  • Jun OuyangEmail author
  • Donggen Zhou
  • Shizhen Zhong
  • Minjie Wen
  • Wentao Ou
  • Haitao Yu
  • Lin Jia
  • Yaoxin Huang
Original Article



Gastric adenocarcinoma predictive long intergenic noncoding RNA (GAPLINC) has been detected in colorectal cancer (CRC) cells and reportedly performs many functions related to tumor proliferation and metastasis. Aim The present study aimed to comprehensively explore the biological functions of GAPLINC and their underlying mechanism in CRC cell.


The human cancer LncRNA PCR array was used to detect the differentially expressed long noncoding RNAs in human CRC samples. Real-time PCR, dual-luciferase assay, RNA pull-down assay, Transwell assay, and western blot analysis were performed to explore the molecular mechanism underlying GAPLINC functions related to migration and invasion of a human CRC cell line (HCT116).


Compared to the non-cancerous tissues, GAPLINC expression was obviously increased in CRC tissues. In HCT116, silencing of GAPLINC weakened cell migration and invasion, while overexpression of GAPLINC significantly promoted cell migration and invasion. Through dual-luciferase, RNA pull-down, and Transwell assays, we verified that miR-34a was the downstream molecule of GAPLINC and that miR-34a negatively regulated the migration and invasion of HCT116 cell. Furthermore, we found that GAPLINC positively regulated the miR-34a target gene c-MET in CRC tissues.


Our findings revealed that GAPLINC was up-regulated in CRC tissues and was involved in the migration and invasion of CRC cells by regulating miR-34a/c-MET signaling pathway.


LncRNA-GAPLINC miR-34a c-MET Colorectal cancer HCT116 



This work was sponsored by the grant from the Guangzhou Medical and Health Technology Project (No. 20171A011245) and Guangzhou Integrated TCM&WM Technology Project (No. 20172A011001).

Author’s contribution

JOY and YQL conceived and designed the experiments; YQL, SZZ, and QGZ performed the experiments; MJW, WTO, HTY, and YXH analyzed the data; JOY and YQL wrote the paper; JOY, YQL, and QGZ revised the paper.

Compliance with ethical standards

Conflicts of interest

The authors declare no conflict of interest.

Supplementary material

10620_2018_4915_MOESM1_ESM.docx (21 kb)
Supplementary material 1 (DOCX 21 kb)


  1. 1.
    Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767.CrossRefPubMedGoogle Scholar
  2. 2.
    Vinson KE, George DC, Fender AW, et al. The Notch pathway in colorectal cancer. Int J Cancer. 2016;138:1835–1842.CrossRefPubMedGoogle Scholar
  3. 3.
    Yashiro M. Molecular alterations of colorectal cancer with inflammatory bowel disease. Dig Dis Sci. 2015;60:2251–2263.CrossRefPubMedGoogle Scholar
  4. 4.
    Karsa LV, Lignini TA, Patnick J, et al. The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol. 2010;24:381–396.CrossRefPubMedGoogle Scholar
  5. 5.
    Djebali CA, Davis A, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012;489:101–108.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Cullen BR. MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol. 2013;14:205–210.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–641.CrossRefPubMedGoogle Scholar
  8. 8.
    Schmitt AM, Chang HY. Gene regulation: long RNAs wire up cancer growth. Nature. 2013;500:536–537.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Huang T, Alvarez A, Hu B, et al. Noncoding RNAs in cancer and cancer stem cells. Chin J Cancer. 2013;32:582–593.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Wang Y, Zhang L, Zheng X, et al. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis. Cancer Lett. 2016;382:137–146.CrossRefPubMedGoogle Scholar
  11. 11.
    Wei X, Wang C, Ma C, et al. Long noncoding RNA ANRIL is activated by hypoxia-inducible factor-1alpha and promotes osteosarcoma cell invasion and suppresses cell apoptosis upon hypoxia. Cancer Cell Int. 2016;16:73.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Xie CH, Cao YM, Huang Y, et al. Long non-coding RNA TUG1 contributes to tumorigenesis of humanosteosarcoma by sponging miR-9-5p and regulating POU2F1 expression. Bio Med Res Int. 2016;37:15031–15041.Google Scholar
  13. 13.
    Zheng H, Min J. Role of long noncoding RNA HOTAIR in the growth and apoptosis of osteosarcoma cell MG-63. Bio Med Res Int. 2016;2016:5757641.Google Scholar
  14. 14.
    Liu H, Wang G, Yang L, et al. Knockdown of long non-coding RNA UCA1 increases the tamoxifen sensitivity of breast cancer cells through inhibition of Wnt/beta-catenin pathway. PLoS One. 2016;11:e0168406.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Ouimet M, Drouin S, Lajoie M, et al. A childhood acute lymphoblastic leukemia- specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration. Oncotarget. 2017;8:7477–7488.CrossRefPubMedGoogle Scholar
  16. 16.
    Ren K, Li Z, Li Y, et al. Long non-coding RNA taurine up regulated gene 1 promotes cell proliferation and invasion in gastric cancervia negatively modulating miRNA-145-5p. Oncol Res. 2017;25:789–798.CrossRefPubMedGoogle Scholar
  17. 17.
    Yang ZY, Yang F, Zhang YL, et al. LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression. Cancer Biomark. 2017;18:95–104.CrossRefPubMedGoogle Scholar
  18. 18.
    Hu Y, Wang J, Qian J, et al. Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. Cancer Res. 2014;74:6890–6902.CrossRefPubMedGoogle Scholar
  19. 19.
    Liu L, Zhao X, Zou H, et al. Hypoxia promotes gastric cancer malignancy partly through the HIF-1α dependent transcriptional activation of the long non-coding RNA GAPLINC. Front Physiol. 2016;7:420.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Yang P, Chen T, Xu Z, et al. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO. Oncotarget. 2016;7:42183–42194.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Wu XL, He XX, Li S, et al. Long non-coding RNA ucoo2kmd.1 regulates CD44- dependent cell growth by competing for miR-211-3p in colorectal cancer. PLoS One. 2016;11:e0151287.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Fang XY, Pan HF, Leng RX, et al. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett. 2015;356:357–366.CrossRefPubMedGoogle Scholar
  23. 23.
    Schweiger T, Starkl V, Glueck O, et al. Clinical impact of c-MET expression and mutational status in patients with colorectal cancer lung metastases. Eur J Cardiothorac Surg. 2016;49:1103–1111.CrossRefPubMedGoogle Scholar
  24. 24.
    Al-Maghrabi J, Emam E, Gomaa W, et al. c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence. BMC Cancer. 2015;15:676.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Shoji H, Yamada Y, Taniguchi H, et al. Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection. Cancer Sci. 2014;105:1002–1007.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Huang G, Zhu H, Shi Y, et al. cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/beta-catenin pathway. PloS One. 2015;10:e0131225.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Zhao JW, Cheng LM. Long non-coding RNA CCAT1/miR-148a axis promotes osteosarcoma proliferation and migration through regulating PIK3IP1. Acta Biochim Biophys Sin. 2017;25:1–10.CrossRefGoogle Scholar
  28. 28.
    Lehmann U, Kreipe H. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods. 2001;25:409–418.CrossRefPubMedGoogle Scholar
  29. 29.
    He ZZ, Wang YJ, Huang GF, et al. The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting Iaspp. Arch Biochem Biophys. 2017;623–624:1–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Li N, Zhou P, Zheng J, et al. A polymorphism in the lincRNAENST00000515084 exon was found to modulate breast cancer risk via GWAS-based association analyses. PLoS One. 2014;9:e98251.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Zhang M, Liu Y, Yu B, et al. Over-expression of long non-coding RNA GAPLINC promotes colorectal cancer cell metastasis and poor prognosis. Int J Clin Exp Med. 2016;9:3203–3208.Google Scholar
  32. 32.
    Yu F, Zheng J, Mao Y, et al. Long non-coding RNA growth arrest-specific transcript5 (GAS5) inhibits liver fibrogenesis through a mechanism of competing endogenous RNA. J Biol Chem. 2015;290:28286–28298.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Yang F, Huo XS, Yuan SX, et al. Repression of the long noncoding RNALET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell. 2013;49:1083–1096.CrossRefPubMedGoogle Scholar
  34. 34.
    Orom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell.. 2010;143:46–58.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Geisler S, Lojek L, Khalil AM, et al. Decapping of long noncoding RNAs regulates inducible genes. Mol Cell. 2012;45:279–291.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Ma MZ, Li CX, Zhang Y, et al. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Mol Cancer. 2014;13:156.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Steele G Jr, Busse P, Huberman MS, et al. A pilot study of sphincter-sparing management of adenocarcinoma of the rectum. Arch Surg. 1991;126:696–701.CrossRefPubMedGoogle Scholar
  38. 38.
    Li W, Zheng J, Deng J, et al. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells. Gastroenterology. 2014;146:1714–1726.CrossRefPubMedGoogle Scholar
  39. 39.
    Ma Y, Yang Y, Wang F, et al. Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/beta-catenin signalling pathway via suppression of activator protein 2alpha. Gut. 2015;0:1–12.Google Scholar
  40. 40.
    Wang Q, Yang L, Hu X, et al. Up regulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo. Oncotarget. 2016;8:3441–3453.PubMedCentralGoogle Scholar
  41. 41.
    Nissan A, Stojadinovic A, Mitrani-Rosenbaum S, et al. Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues. Int J Cancer. 2012;130:1598–1606.CrossRefPubMedGoogle Scholar
  42. 42.
    Chen J, Zhang K, Song H, et al. Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells. Oncotarget. 2016;7:62474–62489.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Guo X, Hua Y. CCAT1: an oncogenic long noncoding RNA in human cancers. J Cancer Res Clin Oncol. 2017;143:555–562.CrossRefPubMedGoogle Scholar
  44. 44.
    Wang ZH, Guo XQ, Zhang QS, et al. Long non-coding RNA CCAT1 promotes glioma cell proliferation via inhibiting microRNA-410. Biochem Biophys Res Commun. 2016;480:715–720.CrossRefPubMedGoogle Scholar
  45. 45.
    Zhang E, Han L, Yin D, et al. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Res. 2016;45:3086–3101.CrossRefPubMedCentralGoogle Scholar
  46. 46.
    Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol. 1998;16:395–419.CrossRefPubMedGoogle Scholar
  47. 47.
    De Luca T, Pelosi A, Trisciuoglio D, et al. MiR-211 and MITF modulation by Bcl-2 protein in melanoma cells. Mol Carcinog. 2016;55:2304–2312.CrossRefPubMedGoogle Scholar
  48. 48.
    Kim UJ, Lee MN, Kim EJ, et al. MicroRNA miR-199a regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem. 2008;283:18158–18166.CrossRefPubMedGoogle Scholar
  49. 49.
    He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130–1134.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Li N, Fu H, Tie Y, et al. MiR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 2009;275:44–53.CrossRefPubMedGoogle Scholar
  51. 51.
    Dang Y, Luo D, Rong M, et al. Underexpression of miR-34a in Hepatocellular Carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET. PLoS One. 2013;8:e61054.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Anatomy, School of Basic Medical SciencesSouthern Medical UniversityGuangzhouChina
  2. 2.Department of General Surgery, Nansha Hospital of Guangzhou First People’s HospitalGuangzhou Medical UniversityGuangzhouChina
  3. 3.Ningbo international Travel Healthcare CenterNingboChina
  4. 4.Department of Gastroenterology, Nansha Hospital of Guangzhou First People’s HospitalGuangzhou Medical UniversityGuangzhouChina

Personalised recommendations